Tuberculosis surge: Killing more people worldwide than Covid-19 or AIDS
Tuberculosis surge killing people at alarming rate around the world.
Related Articles
Social prescribing: an inadequate response to the degradation of social care in mental health | BJPsych Bulletin | Cambridge Core
Social prescribing: an inadequate response to the degradation of social care in mental health – Volume 48 Issue 1
So you’ve found research fraud. Now what?
Harvard dishonesty researcher Francesca Gino faked her research. But she still has a lot to teach us.
The Health Costs of Cost-Sharing*
Abstract. What happens when patients suddenly stop their medications? We study the health consequences of drug interruptions caused by large, abrupt, and a
How subtle forms of misinformation affect what we buy and how much we trust brands
Trust in brands may be eroded as awareness of misinformation increases according to new research.
Inefficiency is a major problem in the orthopaedic surgery and treatment of MSK diseases
The following text was written by my esteemed research colleague and a collaborator Teemu Karjalainen. It was published as a scientific editorial in the Finnish…
Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer – PubMed
Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer
Bridging the gap between practice guidelines and clinical practice: results from a consumer-oriented evaluation of sexual aids
Sexual health is often negatively impacted by cancer therapies. Using a consumer-oriented approach, our aim was to identify non-pharmacologic sexual aids available online to increase…
Implementation of a shared decision making process for severe stroke-a mixed methods study
Background Clinical decisions made early after stroke can make the difference between survival with disability or death. We aimed to develop, implement and evaluate a…
Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials
This systematic review examines the accuracy of published estimates of event rates and effect sizes in contemporary cardiovascular randomized clinical trials.